Recruiting

Hypertension Management

Sponsor:

Louisiana State University Health Sciences Center in New Orleans

Code:

NCT03579108

Conditions

Hypertension

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Retrospective Chart Review

Study Details

Brief summary:

High blood pressure is the greatest threat to the global burden of disease, contributing to an estimated 9.4 million deaths a year. Cardiovascular disease morbidity and mortality are positively correlated with the degree of elevation of blood pressure, without any evidence of a threshold down to at least 115/75 mm Hg\[2\]. Hypertension is common, and nearly every clinician in every specialty deals either directly or indirectly with managing it or its consequences.

The population age 65 years or older numbered 46.2 million in 2014 and they represent 14.5% of the US population, the older population in 2030 is projected to be more than twice as large as in 2000, growing from 35 million to 74 million and representing 21 percent of the total U.S. population and it is expected to more than double to 98 million in 2060.Proper managing and controlling blood pressure markedly improves patient morbidity and mortality, SHEP study showed that in persons aged 60 years and over with isolated systolic hypertension, antihypertensive stepped-care drug treatment with low-dose chlorthalidone as step 1 medication reduced the incidence of total stroke by 36%.This study will estimate the prevalence of hypertension diagnosis, treatment and outcomes in a Family Practice population. It is a hypothesis generating study

Conditions

Hypertension

Study ID

NCT03579108

Start date

Feb 24, 2018

Status verified date

May, 2021

Completion date

Aug 31, 2024

Anticipated

Primary completion date

May 1, 2024

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria

  • hypertension

Exclusion Criteria:

  • No hypertension

Study Design

Enrollment

200 participants

Anticipated

Interventions and Outcome Measures

Interventions

Retrospective Chart Review

Chart review

Primary outcome measure

  • controlled hypertension [ Time Frame: 3 months ]

Central Contacts and Locations

Central contacts

Erwin A Aguilar, PharmD,, MPH

504-568-8655eaguil@lsuhsc.edu

Locations

LSU Health Sciences Center

Recruiting

New Orleans, Louisiana, United States, 70112

Contacts

Principal Investigator:

Erwin A Aguilar, PharmD

More Information

Sponsor

Louisiana State University Health Sciences Center in New Orleans

Last update posted

May 20, 2021

Last verified

May, 2021

Keywords

  • Hypertension

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Louisiana State University Health Sciences Center in New Orleans on 2021-05-20.